Trials / Completed
CompletedNCT04398732
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
Efficacy of Etanercept in Iraqi Patients With Moderate to Severe Psoriasis: 5 Years Data From Local Registry.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 486 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate available local data in Iraqi patients with moderate to severe psoriasis on Enbrel treatment with regards to efficacy, treatment regimen adherence and patient characterization (i.e. age, gender, smoking status) using data from the Dermatologists in Baghdad Teaching Hospital registry
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enbrel | As provided in real world practice |
Timeline
- Start date
- 2020-07-05
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2020-05-21
- Last updated
- 2021-11-01
- Results posted
- 2021-11-01
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT04398732. Inclusion in this directory is not an endorsement.